Sodium Aescinate

CAS No. 20977-05-3

Sodium Aescinate( —— )

Catalog No. M13308 CAS No. 20977-05-3

Extracted from Aesculus wilsonii;Store the product in sealed,cool and dry condition.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
5MG 49 In Stock
10MG 66 In Stock
25MG 119 In Stock
50MG 168 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sodium Aescinate
  • Note
    Research use only, not for human use.
  • Brief Description
    Extracted from Aesculus wilsonii;Store the product in sealed,cool and dry condition.
  • Description
    Extracted from Aesculus wilsonii;Store the product in sealed,cool and dry condition.(In Vitro):Sodium aescinate can block signals transiting to downstream molecules AKT, ERK, inhibit the proliferation of breast cancer cell MCF-7 cell apoptosis and induced cell apoptosis by suppressing the activation of SRC.(In Vivo):Sodium aescinate may effectively controls and improves wound healing in diabetic rats via its anti-inflammatory and antioxidant activities.Sodium aescinate treatment can alleviate the symptom of polycystic ovary syndrome (PCOS) in rat model through regulating the PI3K/Akt/GSK3-β pathway.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    HIF/HIF Prolyl-hydroxylase
  • Recptor
    HIF-1α
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    20977-05-3
  • Formula Weight
    1123.21
  • Molecular Formula
    C54H83NaO23
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    CC(C(C)OC(=O)C)C(=O)OCC12[C@H]3C[C@@]4(C(=CCC5C4(CCC6C5(CCC([C@]6(C)CO)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O[C@@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)C)C)C1CC([C@@H](C2O)O3)(C)C)C.[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kang J, et al. World J Emerg Med. 2013;4(1):63-8.
molnova catalog
related products
  • JTZ-951 hydrochlorid...

    A novel potent, orally active HIF prolyl hydroxylase (PHD) inhibitor with IC50 of 0.22 uM for PHD2.

  • Dimethyloxaloylglyci...

    DMOG is an antagonist of α-ketoglutarate cofactor and inhibitor for HIF prolyl hydroxylase.

  • JNJ-42041935

    JNJ-42041935 is a potent, selective, 2-OG-competitive, reversible inhibitor of HIF-PHD.